Oral shedding of human herpesviruses and cytokine profiles in children and adolescents undergoing chemotherapy
DOI:
https://doi.org/10.5327/2525-5711.467Keywords:
Cytokines, Saliva, Cancer survivors, Oral shedding, Human herpesvirusesAbstract
Objective: To characterize oral shedding of human herpesviruses (HHVs) and their association with salivary inflammatory cytokines in children and adolescents undergoing chemotherapy. Methods: This cross-sectional study included 65 participants: 39 in the study group (SG) and 26 in the control group (CG). Unstimulated saliva was analyzed by PCR for viral detection and quantification, and cytokines levels ((IL-4, IL-6, IL-8, IL-10, IFN-γ, and TNF-α) were measured using the Luminex® platform. Descriptive, comparative, and correlation analyses were performed (p<0.05). Results: In the SG, the most frequently detected viruses were HHV-7, HHV-6, EBV, and CMV. The HHV-7 viral load was significantly greater in the SG than in the CG (6.5 vs. 5.8 cp/mL; p = 0.0288). Only IL-4 differed significantly, with higher levels in the SG (8.4 vs. 7.2 pg/mL; p=0.0374). Weak correlations were found between CMV and IL-6 (r=0.34; p=0.0095) and between HHV-6 and TNF-α (r=–0.33; p=0.0125). Conclusion: Chemotherapy was associated with increased HHV-7 viral load and IL-4 levels, suggesting possible alterations in the oral immune environment, even in the absence of clinical manifestations. Overall, viral load had minimal influence on salivary inflammatory cytokines.
References
1. Miranda-Silva W, Knebel FH, Tozetto-Mendozo TR, Palmieri M, Fonseca FP, Camargo AA, et al. Herpesviruses in the oral cavity of patients subjected to allogeneic hematopoietic stem cell transplantation and its relationship with oral mucositis. Clin Oral Investig. 2020;24(10):3597-08. https://doi.org/10.1007/s00784-020-03234-3
2. Palmieri M, Martins VAO, Sumita LM, Tozetto-Mendoza TR, Romano BB, Machado CM, et al. Oral shedding of human herpesviruses in patients undergoing radiotherapy/chemotherapy treatment for head and neck squamous cell carcinoma. Clin Oral Investig. 2017;21(7):2291-301. https://doi.org/10.1007/s00784-016-2022-x
3. van der Beek MT, Laheij AM, Raber-Durlacher JE, von dem Borne PA, Wolterbeek R, van der Blij-de Brouwer CS, et al. Viral loads and antiviral resistance of herpesviruses and oral ulcerations in hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2012;47(9):1222-8. https://doi.org/10.1038/bmt.2012.2
4. Costa ALF, Santos BA, Torregrossa VR, Miranda ECM, Vigorito AC, Palmieri M, et al. Oral shedding of CMV and HSV-1 in hematopoietic stem cell transplantation patients. Oral Dis. 2021;27(6):1572-79. https://doi.org/10.1111/odi.13690
5. Nicolatou-Galitis O, Athanassiadou P, Kouloulias V, Sotiropoulou-Lontou A, Dardoufas K, Polychronopoulou A, et al. Herpes simplex virus-1 (HSV-1) infection in radiation-induced oral mucositis. Support Care Cancer. 2006;14(7):753-62. https://doi.org/10.1007/s00520-005-0006-5
6. Chen Y-K, Hou H-A, Chow J-M, Chen Y-C, Hsueh P-R, Tien H-F. The impact of oral herpes simplex virus infection and candidiasis on chemotherapy-induced oral mucositis among patients with hematological malignancies. Eur J Clin Microbiol Infect Dis. 2011;30(6):753-9. https://doi.org/10.1007/s10096-010-1148-z
7. Grinde B. Herpesviruses: latency and reactivation - viral strategies and host response. J Oral Microbiol. 2013;5(1):22766. https://doi.org/10.3402/jom.v5i0.22766
8. Agut H, Bonnafous P, Gautheret-Dejean A. Human Herpesviruses 6A, 6B, and 7. Microbiol Spectr. 2016;4(3). https://doi.org/10.1128/microbiolspec.dmih2-0007-2015
9. Raposo JV, Sarmento DJS, Pinto RBDS, Lopes AO, Gallottini M, Tozetto-Mendoza TR, et al. Longitudinal study on oral shedding of human betaherpesviruses 6 and 7 in renal transplant recipients reveals active replication. J Oral Microbiol. 2020;12(1):1785801. https://doi.org/10.1080/20002297.2020.1785801
10. Diesch T, Filippi C, Fritschi N, Filippi A, Ritz N. Cytokines in saliva as biomarkers of oral and systemic oncological or infectious diseases: A systematic review. Cytokine. 2021;143:155506. https://doi.org/10.1016/j.cyto.2021.155506
11. Sahibzada HA, Khurshid Z, Khan RS, Naseem M, Siddique KM, Mali M, et al. Salivary IL-8, IL-6 and TNF-α as Potential Diagnostic Biomarkers for Oral Cancer. Diagnostics (Basel). 2017;7(2):21. https://doi.org/10.3390/diagnostics7020021
12. Rinderknecht C, Filippi C, Ritz N, Fritschi N, Simmen U, Filippi A, et al. Associations between salivary cytokines and oral health, age, and sex in healthy children. Sci Rep. 2022;12(1):15991. https://doi.org/10.1038/s41598-022-20475-2
13. Lima LR, Silva AP, Schmidt-Chanasit J, Paula VS. Diagnosis of human herpes virus 1 and 2 (HHV-1 and HHV-2): use of a synthetic standard curve for absolute quantification by real time polymerase chain reaction. Mem Inst Oswaldo Cruz. 2017;112(3):220-3. https://doi.org/10.1590/0074-02760160354
14. Raposo JV, Alves ADR, Dos Santos da Silva A, Dos Santos DC, Melgaço JG, Moreira OC, et al. Multiplex qPCR facilitates identification of betaherpesviruses in patients with acute liver failure of unknown etiology. BMC Infect Dis. 2019;19(1):773. https://doi.org/10.1186/s12879-019-4309-4
15. Tozetto-Mendoza TR, Ibrahim KY, Tateno AF, de Oliveira CM, Sumita LM, Sanchez MCA, et al. Genotypic distribution of HHV-8 in AIDS individuals without and with Kaposi sarcoma: Is genotype B associated with better prognosis of AIDS-KS? Medicine (Baltimore). 2016;95(48):e5291. https://doi.org/10.1097/MD.0000000000005291
16. Pels E. Comparison of saliva interleukin-2 concentration to the condition of gums in children with acute lymphoblastic leukaemia during anti-tumour treatment. Cancer Chemother Pharmacol. 2015;76(1):205-10. https://doi.org/10.1007/s00280-015-2750-7
17. Szabo YZ, Slavish DC. Measuring salivary markers of inflammation in health research: A review of methodological considerations and best practices. Psychoneuroendocrinology. 2021;124:105069. https://doi.org/10.1016/j.psyneuen.2020.105069
18. Paganini A, Fritschi N, Filippi C, Ritz N, Simmen U, Scheinemann K, et al. Comparative analysis of salivary cytokine profiles in newly diagnosed pediatric patients with cancer and healthy children. Sci Rep. 2025;15(1):3544. https://doi.org/10.1038/s41598-025-87608-1
19. Velten DB, Zandonade E, Miotto MHMB. Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy. BMC Oral Health. 2017;17:49. https://doi.org/10.1186/s12903-016-0331-8
20. Ramphal R, Grant RM, Dzolganovski B, Constantin J, Tellier R, Allen U, et al. Herpes simplex virus in febrile neutropenic children undergoing chemotherapy for cancer: a prospective cohort study. Pediatr Infect Dis J. 2007;26(8):700-4. https://doi.org/10.1097/inf.0b013e31805cdc11
21. Mendonça RMH, Araújo M, Levy CE, Morari J, Silva RA, Yunes JA, et al. Prospective evaluation of HSV, Candida spp, and oral bacteria on the severity of oral mucositis in pediatric acute lymphoblastic leukemia. Support Care Cancer. 2012;20(5):1101-7. https://doi.org/10.1007/s00520-011-1190-0
22. Gantt S, Casper C. Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment. Curr Opin Infect Dis. 2011;24(4):295-301. https://doi.org/10.1097/qco.0b013e3283486d04
23. van Velzen M, Ouwendijk WJD, Selke S, Pas SD, van Loenen FB, Osterhaus ADME, et al. Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV. J Med Virol. 2013;85(9):1669-77. https://doi.org/10.1002/jmv.23634
24. Rechenchoski DZ, Faccin-Galhardi LC, Linhares REC, Nozawa C. Herpesvirus: an underestimated virus. Folia Microbiol (Praha). 2017;62(2):151-6. https://doi.org/10.1007/s12223-016-0482-7
25. Kerr JR. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors. J Clin Pathol. 2019;72(10):651-8. https://doi.org/10.1136/jclinpath-2019-205822
26. Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol. 2021;11:587380. https://doi.org/10.3389/fimmu.2020.587380
27. Silva-Filho JL, Caruso-Neves C, Pinheiro AAS. IL-4: an important cytokine in determining the fate of T cells. Biophys Rev. 2014;6(1):111-8. https://doi.org/10.1007/s12551-013-0133-z
28. Yamanishi K. Human herpesvirus 6. Microbiol Immunol. 1992;36(6):551-61. https://doi.org/10.1111/j.1348-0421.1992.tb02055.x
29. Dagna L, Pritchett JC, Lusso P. Immunomodulation and immunosuppression by human herpesvirus 6A and 6B. Future Virol. 2013;8(3):273-87. https://doi.org/10.2217/fvl.13.7
30. Elad S, Zadik Y, Hewson I, Hovan A, Correa ME, Logan R, et al. A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea. Support Care Cancer. 2010;18(8):993-1006. https://doi.org/10.1007/s00520-010-0900-3
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Wallena Albuquerque da Cunha, Patricia Shibutani , Fabiana Martins e Martins de Oliveira , Luiz Alberto Valente Soares Júnior , Paulo Henrique Braz-Silva, Marina Gallottini

This work is licensed under a Creative Commons Attribution 4.0 International License.











